These signalling pathways are often disrupted in human malignancies, and several NEDD4 family members, including NEDD4, NEDD4L, SMURF1, SMURF2, WWP1 and WWP2, also have altered expression or splicing in cancer [13]. Here, NEDD4 is linked to cancer.